Oncotarget Continues To Spread Knowledge of Aging & Cancer-Causing Agents to Educate Many as Possible

Oncotarget is a multidisciplinary traditional journal with free-access Oncotarget publishes weekly publications online in newspaper formats focusing on a variety of various disciplines and topics. For example, in 2015 we were ranked #1 in oncology by publishing peer-reviews and rebuttals online on the topics. Oncotarget’s very definition is “encompasses all molecules, pathways, and cellular functions common in cancer and aging, neurodegeneration, and atherosclerosis, lymphocytes and neurons, cancer cells, and microbes”. Oncotarget also focuses on covering the various topics of aging, pathology, immunology, microbiology, cell death, and chromosome studies just to name a few other fields they cover under the greater “medical” umbrella.

Oncotarget strives to spread reliable information and make it available to the masses to they can further their own knowledge of cancers and aging-related conditions. Oncotarget also links these concepts to other known conditions and how their findings affect those conditions and subgenres of science. The company wants to get rid of all the lines between subgenres of medical studying, and end up bringing it all together and just study biomedical science as a whole. Oncotarget is also available on Dove Press.

The site runs under the leadership of some of the most prominent scientists in the biomedical fields, and to allow everyone to benefit from all of the various medical advances being made in the biomedical world. The goal of Oncotarget is to have a life and existence for humanity that includes life without disease, and they will not stop researching until they achieve that dream. The Oncotarget’s website has been able to get a higher ranking constantly due to the high volume of peer reviews from highly-credible and highly-trusted sources, and having many doctors and medical professionals on our site as authors continues to help increase our rankings and ratings as well.

Learn more: http://www.bioxbio.com/if/html/ONCOTARGET.html